Maximus/$MMS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Maximus
Maximus Inc designs, develops, and delivers programs, enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments; U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.
Ticker
$MMS
Sector
Business services
Primary listing
NYSE
Employees
41,100
Headquarters
Website
Maximus Metrics
BasicAdvanced
$4.8B
15.78
$5.37
0.57
$1.20
1.42%
Price and volume
Market cap
$4.8B
Beta
0.57
52-week high
$92.50
52-week low
$63.77
Average daily volume
581K
Dividend rate
$1.20
Financial strength
Current ratio
2.273
Quick ratio
2.107
Long term debt to equity
95.511
Total debt to equity
100.483
Dividend payout ratio (TTM)
22.11%
Interest coverage (TTM)
6.85%
Profitability
EBITDA (TTM)
673.985
Gross margin (TTM)
23.98%
Net profit margin (TTM)
5.83%
Operating margin (TTM)
10.30%
Effective tax rate (TTM)
27.64%
Revenue per employee (TTM)
$130,000
Management effectiveness
Return on assets (TTM)
8.26%
Return on equity (TTM)
17.61%
Valuation
Price to earnings (TTM)
15.779
Price to revenue (TTM)
0.912
Price to book
2.69
Price to tangible book (TTM)
-6.05
Price to free cash flow (TTM)
-34.448
Free cash flow yield (TTM)
-2.90%
Free cash flow per share (TTM)
-2.46
Dividend yield (TTM)
1.42%
Forward dividend yield
1.42%
Growth
Revenue change (TTM)
3.40%
Earnings per share change (TTM)
12.65%
3-year revenue growth (CAGR)
5.98%
10-year revenue growth (CAGR)
10.74%
3-year earnings per share growth (CAGR)
21.40%
10-year earnings per share growth (CAGR)
8.53%
3-year dividend per share growth (CAGR)
2.33%
10-year dividend per share growth (CAGR)
20.89%
What the Analysts think about Maximus
Analyst ratings (Buy, Hold, Sell) for Maximus stock.
Bulls say / Bears say
Maximus delivered 2.5% revenue growth to $1.35 billion in Q3 FY2025, driven by 4.3% organic expansion, and raised full-year revenue guidance to $5.375–$5.475 billion (Business Wire)
U.S. Federal Services segment posted 11.4% revenue growth to $761.2 million in Q3 FY2025 and expanded its operating margin to 18.1%, reflecting strong clinical program volumes (Business Wire)
Maximus secured a $77 million cybersecurity and cloud services contract with the U.S. Air Force, expanding its Department of Defense portfolio and underpinning future revenue visibility (Business Wire)
U.S. Services segment revenue fell 6.9% to $439.8 million in Q3 FY2025, with operating margin contracting to 10.2% from 13.0% a year earlier as temporary Medicaid-related volumes normalized (Business Wire)
Outside the U.S. segment revenue decreased to $147.4 million in Q3 FY2025 due to prior divestitures, limiting international growth despite a modest 7.3% organic uptick (Business Wire)
Free cash flow swung to a negative $198.2 million in Q3 FY2025 as Days Sales Outstanding spiked to 96 days, highlighting volatility in cash generation despite subsequent collection improvements (Business Wire)
Data summarised monthly by Lightyear AI. Last updated on 2 Oct 2025.
Maximus Financial Performance
Revenues and expenses
Maximus Earnings Performance
Company profitability
Maximus News
AllArticlesVideos
Maximus Selected to Expand the Impact of Pennsylvania's Health Plan Enrollment Services
Business Wire2 weeks ago
Maximus Board Authorizes Expansion to Purchase Program of Maximus Common Stock
Business Wire1 month ago
Maximus Achieves Cybersecurity Maturity Model Certification (CMMC) Level 2
Business Wire2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Maximus stock?
Maximus (MMS) has a market cap of $4.8B as of October 16, 2025.
What is the P/E ratio for Maximus stock?
The price to earnings (P/E) ratio for Maximus (MMS) stock is 15.78 as of October 16, 2025.
Does Maximus stock pay dividends?
Yes, the Maximus (MMS) stock pays dividends to shareholders. As of October 16, 2025, the dividend rate is $1.2 and the yield is 1.42%. Maximus has a payout ratio of 22.11% on a trailing twelve-month basis.
When is the next Maximus dividend payment date?
The next Maximus (MMS) dividend payment is scheduled for December 01, 2025.
What is the beta indicator for Maximus?
Maximus (MMS) has a beta rating of 0.57. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.